Impact Factor
3.49
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
3.39
486 total citations
h5-index
23
h5 depth signal
Cited share
83.3%
125 of 150
Total citations
486
Citation footprint
Metric signal
3.19
External metric anchor
Self-citation
1.0%
5 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
Brazil
495
China
70
United States
45
Turkey
29
Iran
23
Citing Fields of Research
Musculoskeletal Disorders
409
Auto-Inflammatory Disorders
150
Crop Science
64
Immunology
57
Osteopathies
22
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
2,122
Articles tracked across the journal lifetime
Indexed publication set
150
125 cited publications
Last 12 months
99
8.3 publications/month
Open access share
100.0%
99 OA publications in the last year
Leading citing country
Brazil
495 citing publications
Leading citing field
Musculoskeletal Disorders
409 citing publications
Latest tracked publication
16 October 2026
10 recent records available
Coverage & Indexing History
v58n1suppl., Aug. 2018-
v58n1suppl., Aug. 2018-
Research Focus & Classification
Indexed Subjects
Musculoskeletal Disorders
Issuing & Sponsoring Bodies
issuing body
Sociedade Brasileira de Reumatologia
Broad Categories
Rheumatology
Musculoskeletal Disorders
MeSH Descriptors
Arthritis
Collagen Diseases
Rheumatic Diseases
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1186/s42358-026-00587-3
Open DOI
Meeting the ASDAS low-disease-activity target but not symptom-free: item-level residual symptom burden at 12 months in a Saudi axial spondyloarthritis cohort
Background: Treat-to-target management in axial spondyloarthritis (axSpA) is anchored on ASDAS-CRP, with low disease activity (LDA) defined as ASDAS-CRP < 2.1. Meeting this target, however, does not necessarily imply symptom resolution. ...
02
DOI 10.1186/s42358-026-00581-9
Open DOI
Assessment of pain during intra-articular injection with corticosteroid and its related variables: a cross-sectional study in patients with rheumatic disease
Objectives: To evaluate the mean pain level during intra-articular injection (IAI) with corticosteroid and its associated variables. Methods: A cross-sectional study with adult patients with rheumatic diseases, joint swelling and pain > ...
03
DOI 10.1186/s42358-026-00583-7
Open DOI
COVID-19 is associated with lupus flare and persistent disease activity: longitudinal data from the ReumaCov-Brazil Register study
Background: This study aimed to evaluate flares in systemic lupus erythematosus (SLE) patients over a period of six months after COVID-19. Methods: A multicenter, observational, and prospective cohort study was performed. SLE adult patie...
04
DOI 10.1186/s42358-026-00561-z
Open DOI
Comorbidities, education level, and pain as factors associated with pharmacotherapeutic complexity in rheumatoid arthritis
Objective: To analyze the factors associated with the complexity of pharmacotherapy in individuals with rheumatoid arthritis (RA). Method: A cross-sectional study was conducted in a teaching hospital in the central-western region of Braz...
05
DOI 10.1186/s42358-026-00580-w
Open DOI
Longitudinal analysis of serum B-Cell Activating Factor (BAFF) levels during pregnancy in women with systemic lupus erythematosus
Background: Overexpression of B-Cell Activating Factor (BAFF) supports autoreactive B cells and prevents their deletion, which appears to be strongly linked to the pathogenesis of lupus. This study was developed to evaluate serum BAFF le...
06
DOI 10.1186/s42358-026-00582-8
Open DOI
2025 Recommendations of the Brazilian society of Rheumatology for the non-pharmacological treatment of knee osteoarthritis
Aim: Knee osteoarthritis (OA) remains a major cause of years lived with disability. There are neither disease-modifying drugs nor safe and effective long-term pain killers to treat these patients. Thus, non-pharmacological treatments rem...
07
DOI 10.1186/s42358-026-00579-3
Open DOI
Autologous hematopoietic stem cell transplantation modulates epidermal-related inflammation/fibrosis mechanisms in systemic sclerosis patients
Background: Autologous hematopoietic stem cell transplantation (auto-HSCT) has been shown to reduce cutaneous fibrosis and change dermal architecture in skin of systemic sclerosis (SSc) patients. However, its impact on the epidermis rema...
08
DOI 10.1186/s42358-026-00578-4
Open DOI
Beyond strongyloides: rationale for empirical antiparasitic prophylaxis in immunosuppressed patients with rheumatic diseases in endemic areas
Background: Intestinal parasitic infections remain highly prevalent in endemic regions such as Brazil and pose a significant risk to patients with immune-mediated rheumatic diseases (IMRDs) undergoing immunosuppressive therapy. Immunosup...
09
DOI 10.1186/s42358-026-00556-w
Open DOI
Imaging-detected tenosynovitis in rheumatoid arthritis: from early diagnosis to disease monitoring
This narrative review provides an updated overview of the pivotal role of imaging-detected tenosynovitis in the diagnosis and management of rheumatoid arthritis (RA). Tenosynovitis emerges as one of the earliest pathological events in in...
10
DOI 10.1186/s42358-026-00568-6
Open DOI
Development of an ultrasound score (US20BR) with small, medium, and large joints: a cross-sectional study in rheumatoid arthritis
Objectives: To identify joint recesses with the strongest correlations between ultrasonographic and clinical variables to develop a Brazilian ultrasound-based joint score(USBR Score) for rheumatoid arthritis(RA) patients. Methods: A cros...
Bibliographical & Catalog Notes
Supplement for Volume 58, issue 1 published earlier.
Some issues have supplements.
Search interface available in English and German.
Official journal of the Brazilian Society of Rheumatology.